Searched for
OSTEOPOROSIS DRUGS
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Lupin inks licensing pact with Japan-based I'rom GroupDenosumab is indicated for the treatment of postmenopausal women with osteoporosis at high risk of fracture and prevention of skeletal-rela...
- World Osteoporosis Day: Laziness is making your bones weak; healthy diet with milk, eggs & nuts will helpAdequate sleep of 6-8 hours daily is also essential for the body to repair.
- Lupin launches Amabelz tablets in US marketThe company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...
- Are you addicted to smoking pot? It may make your bones brittleThe study also found that heavy cannabis users have a lower body weight and a reduced body mass index.
- Lupin launches generic Femhrt tablets in USDrug firm Lupin has launched its generic norethindrone acetate and ethinyl estradiol tablets used for the prevention of postmenopausal oste...
- Aurobindo Pharma gets final USFDA nod for osteoporosis drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, in the American mar...
- Sun Pharma slips over 2% on recall of osteoporosis drug in USThe recall of 3,81,120 cartons of Alendronate Sodium tablets has been initiated by Sun Pharma Global Fze, an arm of the Indian pharma major.
- Sun Pharma recalls 3.8 lakh cartons of osteoporosis drug in USThe recall of 3,81,120 cartons of Alendronate Sodium tablets has been initiated by Sun Pharma Global Fze, an arm of the Indian pharma major.
- Lupin gets FDA approval for generic Femhrt tabletsThe company has received received the final approval from the United States Food and Drug Administration to market Fyavolv tablets, it said.
- Aurobindo gets USFDA nod to market generic Osteoporosis drugThe company has received final approval from US Food & Drug Administration (USFDA) to manufacture and market Risedronate Sodium tablets, Au...
- Aurobindo Pharma gains on USFDA approval for generic osteoporosis drugShares of Aurobindo Pharma gained 3.3 per cent in trade on Monday, after the company got US FDA nod for generic osteoporosis drug.
- Pharma sector to soon showcase new drugs: Harsh VardhanThe Minister announced that CDRI is carrying out IND studies on lead molecules for fracture-healing, cancers, thrombosis, malaria and hyper...
- Glenmark gets USFDA nod for post-menopause osteoporosis drugThe approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenma...
- Eli Lilly launches new drug administering deviceDrug firm ELi Lilly and Company today announced the launch of new drug administering device, used in the treatment of patient suffering fro...
- Ranbaxy to market Daiichi's products in RomaniaDrug firm Ranbaxy Laboratories today said its Romanian arm will market Daiichi Sankyo's drug Evista, used in treatment of osteoporosis, in ...
- Ranbaxy Lab's Romania unit to market osteoporosis drugPharma firm Ranbaxy Laboratories said its Romanian arm will market Evista, a drug used for treating osteoporosis.
- Ranbaxy launches Bio-generic injectable for OsteoporosisRanbaxy Laboratories Ltd on Thursday announced the launch of 'BONISTA- Teriparatide' injection used in the treatment of Osteoporosis diseas...
- Roche signs marketing pact with Elder PharmaRoche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.
Load More
